FY2022 NIH awards · Principal investigators
Internal Medicine at UT MD Anderson Cancer Center
Houston, TX
- NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
- These are the awards in the Internal Medicine row of the UT MD Anderson Cancer Center page.
Leads a grant in this department
106 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.
Davies, Michael
Leads 2 awards · $2,650,320
- 5P50CA221703-04Department: NIH department codeThe University of Texas MD Anderson Cancer Center SPORE in Melanoma$2,058,691award amount
- 5T32CA009666-28Department: NIH department codeResearch Training in Academic Medical Oncology$591,629award amount
Bollard, Catherine M.
Leads 1 award · $2,549,929
- 5P01CA148600-11Department: NIH department codeNovel Cord Blood-Derived Cellular Therapies$2,549,929award amount
Richie, Ellen R
Leads 1 award · $2,309,862
- 5P01AI139449-03Department: NIH department codeMechanisms controlling distinct growth and functional characteristics of the perinatal and adult thymus$2,309,862award amount
Kopetz, Scott
Leads 1 award · $2,211,341
- 5P50CA221707-04Department: NIH department codeMD Anderson Cancer Center SPORE in Gastrointestinal Cancer$2,211,341award amount
Konopleva, Marina Y
Leads 4 awards · $2,083,045
- 5P50CA100632-20Department: NIH department codeSPORE University of Texas M. D. Anderson Cancer Center-Leukemia$1,689,836award amount
- 1R21CA259324-01A1Department: NIH department codeDefining the novel cancer testis antigen HSPA1L as immunotherapeutic target in AML$227,205award amount
- 5R01CA235622-04Department: NIH department codeTargeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen$95,960award amount
- 5R01CA231364-04Department: NIH department codeTargeting mitochondrial complex I in acute lymphoblastic leukemia$70,044award amount
Hunt, Kelly K
Leads 1 award · $1,911,906
- 5UG1CA233329-04Department: NIH department codeUT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1$1,911,906award amount
Wood, Richard D
Leads 1 award · $1,805,617
- 5P01CA193124-06Department: NIH department codeProcessing and Repair of DNA Crosslinks$1,805,617award amount
Green, Michael Richard
Leads 3 awards · $1,515,559
- 1R01CA266279-01A1Department: NIH department codeBAF complex deregulation in lymphoma$701,610award amount
- 5R01CA240839-02Department: NIH department codeFunctional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma$432,113award amount
- 2R01CA201380-06A1Department: NIH department codeIdentifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation$381,836award amount
Abe, Jun-Ichi
Leads 2 awards · $1,277,658
- 5R01HL149303-04Department: NIH department codePathological flow-induced endothelial damage and plaque erosion$782,390award amount
- 5U01AI156921-03Department: NIH department codeMitigating radiation-induced cardiovascular disease by inhibiting premature aging$495,268award amount
Rai, Kunal
Leads 3 awards · $1,125,072
- 5R01CA245395-03Department: NIH department codeUCHL5 as a regulator and therapeutic target in metastatic melanoma$403,228award amount
- 5R01CA226269-03Department: NIH department codeRole of UBR7, a novel H2BK120 E3 ubiquitin ligase, in suppression of breast cancer$363,164award amount
- 5R01CA222214-05Department: NIH department codeRole of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma$358,680award amount
Heymach, John V.
Leads 2 awards · $1,112,869
- 5R01CA247975-03Department: NIH department codeMolecular features impacting drug resistance in atypical EGFR exon 18 and exon 20 mutant non-small cell lung cancers and the development of novel mutant-selective inhibitors$566,537award amount
- 5R01CA234183-03Department: NIH department codeTherapeutic strategies against EGFR exon 20 mutant lung cancer$546,332award amount
Giordano, Sharon Hermes
Leads 1 award · $1,091,199
- 5U54CA096300-19Department: NIH department codeUPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)$1,091,199award amount
Chen Yu
Leads 1 award · $1,005,497
- 5U01CA224044-04Department: NIH department codePatient-Derived Models of Prostate Cancer for Personalized Medicine$1,005,497award amount
Byers, Lauren Averett
Leads 2 awards · $980,661
- 5U01CA256780-02Department: NIH department codeMolecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response$593,411award amount
- 2R01CA207295-06A1Department: NIH department codeDNA damaging therapy and immune response in small cell lung cancer subtypes$387,250award amount
Bhalla, Kapil
Leads 2 awards · $953,316
- 5R01CA255721-02Department: NIH department codeBiology and novel therapy of AML expressing somatic or germline mutant RUNX1$486,972award amount
- 5R01CA233457-03Department: NIH department codeTargeting dysregulated transcriptome as therapy for post-myeloproliferative neoplasm (MPN) sAML$466,344award amount
Kurie, Jonathan M
Leads 2 awards · $953,176
- 5R01CA251067-02Department: NIH department codeElucidating pro-metastatic collagen modifying activities of lysyl hydroxylase 2$527,918award amount
- 5R01CA255021-02Department: NIH department codeA pro-metastatic secretory pathway activated by p53 loss in lung cancer$425,258award amount
Bartholomew, Blaine
Leads 2 awards · $912,476
- 5R01GM131639-04Department: NIH department codeRegulation of RNA polymerase II pausing and directionality by ATP-dependent chromatin remodelers$457,256award amount
- 5R01GM108908-07Department: NIH department codeRegulation of chromatin organization and dynamics by INO80$455,220award amount
Brown, Powel H
Leads 1 award · $911,328
- 5UG1CA242609-04Department: NIH department codeiCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium$911,328award amount
Evans, Scott E.
Leads 1 award · $880,000
- 5R35HL144805-04Department: NIH department codeInducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia$880,000award amount
Hui, David
Leads 2 awards · $876,034
- 5R01CA231471-03Department: NIH department codeEfficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients$441,646award amount
- 5R01CA225701-04Department: NIH department codeStrategies for Persistent Agitated Delirium in Palliative Care$434,388award amount
Danesh, Farhad R
Leads 2 awards · $812,388
- 5R01DK091310-13Department: NIH department codeMicroRNA In Diabetic Nephropathy$455,988award amount
- 5R01DK078900-14Department: NIH department codeRole of Rho Kinase in Diabetic Nephropathy$356,400award amount
Bresalier, Robert S
Leads 1 award · $803,955
- 2U01CA086400-21Department: NIH department codeGreat Lakes New England Clinical Validation Center$803,955award amount
Hanash, Samir M
Leads 1 award · $792,272
- 1U01CA271888-01Department: NIH department codeClinical Validation Center for Lung Cancer Early Detection$792,272award amount
Genovese, Giannicola
Leads 2 awards · $790,527
- 5R01CA258226-02Department: NIH department codeInvestigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma$563,322award amount
- 1R21CA259799-01A1Department: NIH department codeClonal drivers of resistance to immune checkpoint blockade in liver malignancies$227,205award amount
Zhang, Rugang
Leads 2 awards · $735,702
- 7R01CA239128-05Department: NIH department codeSynthetic lethality based combination approaches to ARID1A mutation in ovarian cancer$372,161award amount
- 7R01CA260661-02Department: NIH department codeMetabolic basis of ARID1A-mutated ovarian cancer$363,541award amount
Afshar-Kharghan, Vahid
Leads 2 awards · $720,074
- 5R01CA177909-09Department: NIH department codePlatelets promote growth of ovarian cancer$479,382award amount
- 5R01CA231141-05Department: NIH department codeGenetics of Graft-versus-Host Disease$240,692award amount
Reyes-Gibby, Cielito C
Leads 1 award · $709,427
- 1R01CA267856-01Department: NIH department codeImproving emergency care and outcomes of immune-related adverse events: The immune-related emergency disposition index (IrEDi)$709,427award amount
Bast, Robert C
Leads 1 award · $691,698
- 2K12CA088084-21Department: NIH department codePaul Calabresi Clinical Oncology Award$691,698award amount
Johnson, Faye
Leads 1 award · $671,730
- 1R01CA269516-01Department: NIH department codeTargeting head and neck cancer cells and the adverse tumor microenvironment with a novel small-molecule STAT3 inhibitor$671,730award amount
Patel, Sapna
Leads 1 award · $668,196
- 1R01CA266714-01A1Department: NIH department codeImmunotherapy of Uveal Melanoma using PRAME Vaccine in Combination with Adoptive T Cell Therapy$668,196award amount
Lipkin, Steven M
Leads 1 award · $661,865
- 5R01CA257375-02Department: NIH department codeCancer Immune-Interception for Lynch Syndrome$661,865award amount
Gray, Stanton Bradley
Leads 1 award · $646,311
- 1R01CA260761-01A1Department: NIH department codeCancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome$646,311award amount
Mazur, Pawel K.
Leads 1 award · $642,253
- 1R01CA266280-01Department: NIH department codeTumor cell lineage diversity and composition in gastric cancer progression and therapy resistance$642,253award amount
Frederick, Mitchell J.
Leads 1 award · $637,606
- 5R01CA235620-04Department: NIH department codeTargeting Alterations of the NOTCH1 Pathway in Head & Neck Squamous Cell Carcinoma (HNSCC)$637,606award amount
Yee, Cassian
Leads 1 award · $613,867
- 5R01CA237672-04Department: NIH department codeAdoptive T Cell Therapy for Pancreatic Cancer$613,867award amount
Amin, Hesham M
Leads 1 award · $608,661
- 5R01CA260872-02Department: NIH department codeA Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients$608,661award amount
Chen, Jichao
Leads 1 award · $608,155
- 5R01HL130129-07Department: NIH department codeRegulation of mesenchymal cells by epithelial Wnt ligands$608,155award amount
Ma, Jingfei
Leads 1 award · $600,309
- 5R01CA231513-04Department: NIH department codeDevelopment and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications$600,309award amount
Li, Chun
Leads 1 award · $596,833
- 1R01CA258540-01A1Department: NIH department codeDevelopment of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma$596,833award amount
Puduvalli, Vinay K
Leads 1 award · $570,459
- 5R01CA235673-04Department: NIH department codeA Novel Hsp90 Inhibitor as a Chemo and Radiosensitizer in Adults with Glioblastoma$570,459award amount
Dickey, Burton F
Leads 1 award · $537,168
- 5R01HL129795-07Department: NIH department codeControlling the core airway mucin secretion machinery to prevent pathophysiology$537,168award amount
Ueno, Naoto T.
Leads 1 award · $536,764
- 1R01CA258523-01A1Department: NIH department codeDevelopment of a novel therapy targeting the tumor microenvironment in inflammatory breast cancer$536,764award amount
Neelapu, Sattva S
Leads 1 award · $526,490
- 1R01CA273130-01Department: NIH department code[18F]4FN PET Imaging of Innate Immunity Activation During Immunotherapy-Induced Adverse Events$526,490award amount
Bhalla, Kapil
Leads 1 award · $523,503
- 5R01CA262636-02Department: NIH department codeNovel combination therapy for AML expressing mutant RUNX1$523,503award amount
Calin, George A.
Leads 1 award · $501,986
- 5R01CA222007-05Department: NIH department codemiR-155 targeted therapeutics for precision medicine in lung cancer$501,986award amount
Iqbal, Javeed
Leads 1 award · $499,410
- 1R01CA266612-01A1Department: NIH department codeRole of Heat Shock Protein 70 as a Mediator and Therapeutic Target in T-cell Lymphomas$499,410award amount
Fan, Zhen
Leads 1 award · $487,412
- 5R01CA262288-02Department: NIH department codeDeveloping novel bispecific antibodies for cancer treatment$487,412award amount
Yennu, Sriram
Leads 1 award · $475,796
- 5R01CA231521-04Department: NIH department codeA Combination Therapy to Treat Cancer-Related Fatigue$475,796award amount
Viale, Andrea
Leads 1 award · $450,830
- 5R01CA258917-02Department: NIH department codeMitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer$450,830award amount
Green, Michael Richard
Leads 1 award · $444,382
- 5R01CA247883-02Department: NIH department codeRoles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis$444,382award amount
Yao, Wantong
Leads 1 award · $443,465
- 1R37CA272744-01Department: NIH department codeTargeting Acquired Resistance in KRAS Driven Cancers$443,465award amount
Johnson, David G.
Leads 1 award · $435,474
- 5R01CA214723-05Department: NIH department codeThe E2F1 Post-Translational Modification Code$435,474award amount
Sahni, Nidhi
Leads 1 award · $405,000
- 5R35GM137836-03Department: NIH department codeDeciphering Functional Consequences of Specific and Combinatorial Mutations in Protein Interaction Networks$405,000award amount
Xu, Han
Leads 1 award · $405,000
- 5R35GM137927-03Department: NIH department codeComputational approaches for protein functional analysis using CRISPR screens$405,000award amount
Shelburne, Samuel A
Leads 2 awards · $402,073
- 5R21AI156202-02Department: NIH department codeImpact of regulatory cross-talk on the pathophysiology of emergent acapsular group A streptococcus$202,500award amount
- 5R21AI151536-02Department: NIH department codeRole of β-lactamase encoding gene amplification in the development of non-carbapenemase producing, carbapenem-resistant Enterobacteriaceae$199,573award amount
Dent, Sharon Y. R.
Leads 1 award · $400,000
- 5R35GM131678-04Department: NIH department codeGenetic and Molecular Definition of Histone Modifying Enzyme Functions$400,000award amount
Dantzer, Robert
Leads 1 award · $399,810
- 5R01CA193522-08Department: NIH department codeThe Metabolic Basis of Cancer-Related Fatigue$399,810award amount
Peng, Guang
Leads 1 award · $386,539
- 2R01CA181663-07Department: NIH department codeMechanisms of radioresistance and strategies for radiosensitization in ovarian clear cell carcinoma$386,539award amount
Cole, Francesca
Leads 1 award · $386,379
- 5R01HD098129-04Department: NIH department codeHow age-dependent alterations in meiotic recombination cause chromosome mis-segregation in sperm$386,379award amount
Gibbons, Don Lynn
Leads 2 awards · $376,564
- 5R37CA214609-05Department: NIH department codeThe Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer$366,000award amount
- 3R37CA214609-05S1Department: NIH department codeThe Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer$10,564award amount
Lin, Shiaw-Yih
Leads 1 award · $376,433
- 5R01CA251206-02Department: NIH department codeRNase H2 is a novel therapeutic target in triple negative breast cancer$376,433award amount
McAllister, Florencia
Leads 1 award · $370,575
- 5R37CA237384-03Department: NIH department codeDissecting the source and mechanisms of IL-17-mediated modulation of pancreatic tumorigenesis$370,575award amount
Skoulidis, Ferdinandos
Leads 1 award · $370,575
- 5R01CA262469-02Department: NIH department codeUnderstanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer$370,575award amount
Yap, Timothy Anthony
Leads 1 award · $370,575
- 5R01CA255074-02Department: NIH department codeTranscriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors$370,575award amount
Milbury, Kathrin
Leads 1 award · $367,691
- 5R37CA231522-05Department: NIH department codeDyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers$367,691award amount
Zhang, Jianjun
Leads 1 award · $366,000
- 5R01CA234629-04Department: NIH department codeThe molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma$366,000award amount
Fueyo, Juan
Leads 1 award · $363,164
- 5R01CA256006-02Department: NIH department codeGlioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$363,164award amount
Johnson, Faye
Leads 1 award · $363,164
- 5R01CA248205-03Department: NIH department codeHarnessing Aurora kinase inhibition‐induced cell death to enhance immunotherapy in HPV‐driven cancers$363,164award amount
Zuo, Xiangsheng
Leads 1 award · $363,164
- 5R01CA236905-02Department: NIH department codeMolecular Understanding and Targeting of Determinant Factors in Gastric Tumorigenesis$363,164award amount
Colla, Simona
Leads 1 award · $359,657
- 5R01CA222253-05Department: NIH department codeValidation of Critical 1q21 Vulnerabilities in Multiple Myeloma$359,657award amount
Chen, Junjie
Leads 1 award · $358,680
- 5R01CA210929-06Department: NIH department codeDefine redundant functions of H2AX and NBS1 in DNA repair$358,680award amount
George, Goldy C
Leads 1 award · $358,680
- 5R01CA242565-03Department: NIH department codeUse of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy$358,680award amount
Maitra, Anirban
Leads 1 award · $358,680
- 5R01CA220236-05Department: NIH department codeWnt/?-catenin Signaling in Pancreatic Oncogenesis$358,680award amount
Moghaddam, Seyed Javad Mirhassani
Leads 1 award · $358,434
- 5R01CA225977-05Department: NIH department codeImmunotherapeutic Modalities for K-ras Mutant Lung Cancer: Sex- and Cell Type-Specific Roles of IL-6/STAT3 signaling$358,434award amount
Draetta, Giulio Francesco
Leads 1 award · $357,311
- 5R01CA218139-05Department: NIH department codeMedium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme$357,311award amount
Chen, Taiping
Leads 1 award · $324,000
- 5R01HL149751-03Department: NIH department codeEpigenetic regulation of thrombopoiesis$324,000award amount
Millward, Steven W
Leads 1 award · $323,076
- 5R01CA231509-02Department: NIH department codePro-Drug Enolase Inhibitors in Precision Oncology$323,076award amount
Andreeff, Michael
Leads 2 awards · $276,367
- 1R21CA267401-01Department: NIH department codeTherapeutic targeting of p53 reactivation-induced OXPHOS dependency and stress responses to overcome resistance to venetoclax/HMA in AML$189,338award amount
- 5R01FD006118-02Department: NIH department codePh1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)$87,029award amount
Chari, Suresh T.
Leads 1 award · $263,224
- 5U01DK126365-03Department: NIH department codeThe Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer$263,224award amount
Burks, Jared Kyle
Leads 1 award · $258,385
- 5R50CA243707-03Department: NIH department codeSingle Cell Spatial Analysis in Tissue$258,385award amount
Karuturi, Meghan Sri
Leads 1 award · $250,577
- 5K08CA241087-04Department: NIH department codeDeveloping a Decision Tool for Chemotherapy in Older Women with Early Stage Breast Cancer$250,577award amount
Abdi, Salahadin
Leads 1 award · $227,205
- 1R21CA256136-01A1Department: NIH department codeInnovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults with Cancer: A two arm pilot study$227,205award amount
Bachireddy, Pavan
Leads 1 award · $217,528
- 5K08CA248458-03Department: NIH department codeElucidating Human Leukemia and T Cell Interactions within the Tumor Microenvironment$217,528award amount
Casarin, Stefano
Leads 1 award · $203,567
- 1R21CA267312-01A1Department: NIH department codeIntegrating in vivo and in silico models of prostate cancer-bone interactions to overcome anti-tumor therapy resistance$203,567award amount
Hopkins, William D
Leads 1 award · $202,500
- 5R21HD103490-02Department: NIH department codeGenetic determinants of early brain development in an animal model of autism spectrum disorder (ASD)$202,500award amount
Flores, Anthony Richard
Leads 1 award · $198,750
- 5R21AI159059-02Department: NIH department codeDefining novel mechanisms of clonal emergence in Group A Streptococcus$198,750award amount
Mulholland, Michele M
Leads 1 award · $191,448
- 1K01AG078411-01Department: NIH department codeBaboon model of chemotherapy-related cognitive impairment and accelerated aging$191,448award amount
Lopez-Olivo, Maria De Los Angeles
Leads 1 award · $187,514
- 5K08CA237619-03Department: NIH department codeImproving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition$187,514award amount
Hanash, Samir M
Leads 1 award · $185,552
- 5R21CA255581-02Department: NIH department codeProstate cancer-associated SPOP mutations modulate innate immune response and immune checkpoint therapy$185,552award amount
Kim, Sang Taek
Leads 1 award · $170,640
- 5K08AR079587-02Department: NIH department codeCharacterization of altered immunity in patients with inflammatory arthritis induced by immune checkpoint inhibitor therapy$170,640award amount
Lin, Jamie
Leads 1 award · $165,240
- 5K08DK119466-04Department: NIH department codeThe role of ARF6 in the progression of diabetic kidney disease$165,240award amount
Ferrarotto, Renata
Leads 1 award · $162,000
- 1R03DE031333-01A1Department: NIH department codeExploring biomarkers of clinical benefit to VEGFR inhibitor combined with PD-L1 inhibitor in recurrent/metastatic Adenoid Cystic Carcinoma$162,000award amount
Bedford, Mark T.
Leads 1 award · $141,655
- 5R25CA181004-09Department: NIH department codeMD Anderson Science Park Summer Program in Cancer Research SPCR$141,655award amount
Nilsson, Monique B
Leads 1 award · $140,341
- 5R50CA265307-02Department: NIH department codeTargeting EGFR mutant tyrosine kinase inhibitors (TKIs) resistant and drug-tolerant persister cells in non-small cell lung cancer (NSCLC)$140,341award amount
Batista, Marjorie
Leads 1 award · $125,604
- 5R01CA246368-03Department: NIH department codeThe interplay of the immune system, and microbiome in determining outcome of respiratory viral infections in hematopoietic cell transplant recipients and in patients with leukemia$125,604award amount
Hassan, Noha Abdelwahab Hassan Ali
Leads 1 award · $113,868
- 5K01AI163412-02Department: NIH department codeImmune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy$113,868award amount
Xiao, Guan-Yu
Leads 1 award · $110,821
- 5K99CA249048-02Department: NIH department codeA pro-metastatic secretory program activated by epithelial-to-mesenchymal transition$110,821award amount
Makhnoon, Sukh
Leads 1 award · $107,787
- 5K99CA256216-02Department: NIH department codeMultilevel investigation of uncertain and reclassified genomic variants in clinical oncology$107,787award amount
Vila Ellis, Lisandra
Leads 1 award · $104,544
- 5K99HL155845-02Department: NIH department codeMechanism of pulmonary endothelial cell heterogeneity and its role in disease$104,544award amount
Frigo, Daniel Edward
Leads 1 award · $95,765
- 1R03CA270450-01Department: NIH department codeDelineation of the Role of CAMKK2 in Bone-metastatic Prostate Cancer and its Therapeutic Implications$95,765award amount
Kontoyiannis, Dimitrios P
Leads 1 award · $81,000
- 1R03AI166285-01A1Department: NIH department codeDevelopment of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis$81,000award amount
Ayoub, Edward
Leads 1 award · $70,282
- 1F32CA271697-01Department: NIH department codeTargeting Quiescence Pathways to Overcome Chemoresistance in EVI1-Overexpressing Leukemia$70,282award amount
Silverman, Deborah Ann
Leads 1 award · $34,257
- 5F30CA228258-03Department: NIH department codeThe Role of Mutant p53 in Regulating T-cell Immune Evasion in Pancreatic Adenocarcinoma and Other Cancers$34,257award amount
Clowers, Michael Joseph
Leads 1 award · $34,249
- 1F31CA261121-01A1Department: NIH department codeEstrogen receptors restrict tumor-promoting inflammation in K-ras mutant lung cancer$34,249award amount
Wu, Xiangwei
Leads 1 award · $33,593
- 5R01CA214954-05Department: NIH department codeActivating p53 for colorectal cancer prevention$33,593award amount
Grace, Peter M
Leads 1 award · $1
- 5R01CA227064-05Department: NIH department codePQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain$1award amount